Why to measure estrogen receptor status in breast carcinomas?
Pervez, S.
JPMA. Journal of the Pakistan Medical Association 44(6): 132-133
1994
ISSN/ISBN: 0030-9982 PMID: 8089900 Document Number: 424928
Document emailed within 1 workday
Related Documents
Mori, T.; Morimoto, T.; Komaki, K.; Monden, Y. 1989: The receptor status between in primary tumor and in its involved regional node referring to estrogen receptor and epidermal growth factor receptor in human breast cancer: preliminary report Nihon Geka Gakkai Zasshi 90(10): 1820Sartin, E.A.; Barnes, S.; Kwapien, R.P.; Wolfe, L.G. 1992: Estrogen and progesterone receptor status of mammary carcinomas and correlation with clinical outcome in dogs American Journal of Veterinary Research 53(11): 2196-2200
Ferguson, A.T.; Lapidus, R.G.; Baylin, S.B.; Davidson, N.E. 1995: Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression Cancer Research 55(11): 2279-2283
Kamby, C.; Rose, C.; Iversen, H.; Holm, N.V.; Andersen, K.W.; Thorpe, S.M. 1986: The pattern of metastases in breast cancer and the relation to estrogen receptor status Ugeskrift for Laeger 148(40): 2546-2548
Kiang, D.T.; Frenning, D.H.; Gay, J.; Goldman, A.I.; Kennedy, B.J. 1980: Estrogen receptor status and response to chemotherapy in advanced breast cancer Cancer 46(12 Suppl): 2814-2817
Nizamutdinova, I.T.; Lee, G.W.; Son, K.H.; Jeon, S.J.; Kang, S.S.; Kim, Y.S.; Lee, J.H.; Seo, H.G.; Chang, K.C.; Kim, H.J. 2008: Tanshinone i effectively induces apoptosis in estrogen receptor-positive (MCF-7) and estrogen receptor-negative (MDA-MB-231) breast cancer cells International Journal of Oncology 33(3): 485-491
Castles, C.G.; Fuqua, S.A.; Klotz, D.M.; Hill, S.M. 1993: Expression of a constitutively active estrogen receptor variant in the estrogen receptor-negative BT-20 human breast cancer cell line Cancer Research 53(24): 5934-5939
Horwitz, K.B.; McGuire, W.L. 1978: Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor Journal of Biological Chemistry 253(7): 2223-2228
Shao, Z.M.; Sheikh, M.S.; Ordonez, J.V.; Feng, P.; Kute, T.; Chen, J.C.; Aisner, S.; Schnaper, L.; LeRoith, D.; Roberts, C.T. 1992: IGFBP-3 gene expression and estrogen receptor status in human breast carcinoma Cancer Research 52(18): 5100-5103
Masiuk, M. 2006: Expression and intranuclear distribution of nucleolin in estrogen receptor-negative and estrogen receptor-positive breast cancers in women measured by laser scanning cytometry Annales Academiae Medicae Stetinensis 52(2): 23-32
Ellinidi, V.N.; Anikeeva, N.V.; Goncharova, O.A.; Krasnozhon, D.A. 2005: Comparative evaluation of proliferative activity of breast tumors of different estrogen-progesterone receptor status Voprosy Onkologii 51(2): 197-199
Kuo, S.H.; Lin, C.C.; Yu, S.C.; Liaw, K.Y.; Wei, T.C.; Chen, K.M. 1985: Relationship of DNA ploidy, cell kinetics, estrogen receptor and clinical status in patients with breast cancer Journal of the Formosan Medical Association 84(11): 1260-1269
Honig, A.; Gehrmann, M.; Kranke, P.; Keller, D.; Engel, J.B.; Hengstler, S.; Schmidt, M. 2014: Microtubule-associated protein tau correlates with estrogen receptor status but not with in vitro paclitaxel sensitivity in primary breast cancer European Journal of Gynaecological Oncology 35(5): 503-507
Caldarola, L.; Calderini, P.; Volterrani, P.; Di Carlo, F.; Gaglia, P. 1983: The correlation between estrogen receptor status, axillary-node metastases and disease-free interval after surgery in primary breast cancer Italian Journal of Surgical Sciences 13(3): 179-185
DeWys, W.D.; Allegra, J.C.; Simon, R.; Lippman, M.B. 1980: A proposed model for the prediction of response to endocrine therapy in breast cancer from the estrogen receptor status of one site and the number of metastatic sites Cancer Research 40(7): 2423-2427
Wang, S.-l.; Li, Y.-x.; Song, Y.-w.; Wang, W.-h.; Jin, J.; Liu, Y.-p.; Liu, X.-f.; Yu, Z.-h. 2010: Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy Zhonghua Zhong Liu Za Zhi 32(7): 520-525
Thorpe, S.M. 1987: Monoclonal antibody technique for detection of estrogen receptors in human breast cancer: greater sensitivity and more accurate classification of receptor status than the dextran-coated charcoal method Cancer Research 47(24 Pt 1): 6572-6575
Nikolić-Vukosavljević, D.; Grujić-Adanja, G.; Janković, R.; Nesković-Konstantinović, Z.; Branković-Magić, M. 2001: PS2 protein in breast carcinomas: cut-off value of estrogen-regulated expression Neoplasma 48(1): 1-6
Surmacz, E.; Bartucci, M. 2004: Role of estrogen receptor alpha in modulating IGF-i receptor signaling and function in breast cancer Journal of Experimental and Clinical Cancer Research: Cr 23(3): 385-394
Avci, N.; Deligonul, A.; Tolunay, S.; Cubukcu, E.; Fatih Olmez, O.; Ulas, A.; Hartavi, M.; Kurt, E.; Evrensel, T. 2015: Neoadjuvant chemotherapy-induced changes in immunohistochemical expression of estrogen receptor, progesterone receptor, HER2, and Ki-67 in patients with breast cancer Journal of BUON: Official Journal of the Balkan Union of Oncology 20(1): 45-49